UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.

Grieve, R; Roberts, J; Wright, M; Sweeting, M; DeAngelis, D; Rosenberg, W; Bassendine, M; (2006) Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut , 55 (9) 1332 - 1338. 10.1136/gut.2005.064774.

Full text not available from this repository.

Abstract

For patients with mild chronic hepatitis C the cost effectiveness of antiviral therapy is unknown.

Type: Article
Title: Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.
Location: England
DOI: 10.1136/gut.2005.064774
Language: English
Keywords: Adult, Aged, Antiviral Agents, Cost-Benefit Analysis, Disease Progression, Drug Costs, Drug Therapy, Combination, Great Britain, Health Care Costs, Hepatitis C, Chronic, Humans, Interferon-alpha, Middle Aged, Models, Econometric, Polyethylene Glycols, Quality of Life, Quality-Adjusted Life Years, Recombinant Proteins, Ribavirin, Severity of Illness Index
URI: http://discovery.ucl.ac.uk/id/eprint/1340657
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item